131 related articles for article (PubMed ID: 31769548)
1. Deletion of Runx1 in osteoclasts impairs murine fracture healing through progressive woven bone loss and delayed cartilage remodeling.
Paglia DN; Diaz-Hernandez ME; Roberts JL; Kalinowski J; Lorenzo J; Drissi H
J Orthop Res; 2020 May; 38(5):1007-1015. PubMed ID: 31769548
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast depletion with clodronate liposomes delays fracture healing in mice.
Lin HN; O'Connor JP
J Orthop Res; 2017 Aug; 35(8):1699-1706. PubMed ID: 27653179
[TBL] [Abstract][Full Text] [Related]
3. Runx1 Regulates Myeloid Precursor Differentiation Into Osteoclasts Without Affecting Differentiation Into Antigen Presenting or Phagocytic Cells in Both Males and Females.
Paglia DN; Yang X; Kalinowski J; Jastrzebski S; Drissi H; Lorenzo J
Endocrinology; 2016 Aug; 157(8):3058-69. PubMed ID: 27267711
[TBL] [Abstract][Full Text] [Related]
4. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
Kayal RA; Tsatsas D; Bauer MA; Allen B; Al-Sebaei MO; Kakar S; Leone CW; Morgan EF; Gerstenfeld LC; Einhorn TA; Graves DT
J Bone Miner Res; 2007 Apr; 22(4):560-8. PubMed ID: 17243865
[TBL] [Abstract][Full Text] [Related]
5. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
[TBL] [Abstract][Full Text] [Related]
6. Runx1-mediated regulation of osteoclast differentiation and function.
Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
[TBL] [Abstract][Full Text] [Related]
7. Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture.
Lanske B; Chandler H; Pierce A; Brown J; Ominsky M; Kostenuik P; Hattersley G
J Orthop Res; 2019 Apr; 37(4):812-820. PubMed ID: 30790359
[TBL] [Abstract][Full Text] [Related]
8. Role of Fas and Treg cells in fracture healing as characterized in the fas-deficient (lpr) mouse model of lupus.
Al-Sebaei MO; Daukss DM; Belkina AC; Kakar S; Wigner NA; Cusher D; Graves D; Einhorn T; Morgan E; Gerstenfeld LC
J Bone Miner Res; 2014 Jun; 29(6):1478-91. PubMed ID: 24677136
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of PDK1 in osteoclasts delays fracture healing and repair.
Xiao D; Zhou Q; Bai Y; Cao B; Zhang Q; Zeng G; Zong S
Mol Med Rep; 2020 Aug; 22(2):1536-1546. PubMed ID: 32626968
[TBL] [Abstract][Full Text] [Related]
10. Conditional deletion of IGF-I in osteocytes unexpectedly accelerates bony union of the fracture gap in mice.
Lau KW; Rundle CH; Zhou XD; Baylink DJ; Sheng MH
Bone; 2016 Nov; 92():18-28. PubMed ID: 27519969
[TBL] [Abstract][Full Text] [Related]
11. Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing.
Soung do Y; Talebian L; Matheny CJ; Guzzo R; Speck ME; Lieberman JR; Speck NA; Drissi H
J Bone Miner Res; 2012 Jul; 27(7):1585-97. PubMed ID: 22431360
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Notch Signaling in Osteoclasts Improves Bone Regeneration and Healing.
Goel PN; Moharrer Y; Hebb JH; Egol AJ; Kaur G; Hankenson KD; Ahn J; Ashley JW
J Orthop Res; 2019 Oct; 37(10):2089-2103. PubMed ID: 31166033
[TBL] [Abstract][Full Text] [Related]
13. Sexually Dimorphic Increases in Bone Mass Following Tissue-specific Overexpression of Runx1 in Osteoclast Precursors.
Díaz-Hernández ME; Kinter CW; Watson SR; Mella-Velazquez G; Kaiser J; Liu G; Khan NM; Roberts JL; Lorenzo J; Drissi H
Endocrinology; 2022 Sep; 163(9):. PubMed ID: 35880727
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing.
Wang YH; Qiu Y; Han XD; Xiong J; Chen YX; Shi HF; Karaplis A
Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):715-23. PubMed ID: 23937065
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.
Wang T; Wang Y; Menendez A; Fong C; Babey M; Tahimic CG; Cheng Z; Li A; Chang W; Bikle DD
J Bone Miner Res; 2015 Sep; 30(9):1572-84. PubMed ID: 25801198
[TBL] [Abstract][Full Text] [Related]
16. Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing.
Flick LM; Weaver JM; Ulrich-Vinther M; Abuzzahab F; Zhang X; Dougall WC; Anderson D; O'Keefe RJ; Schwarz EM
J Orthop Res; 2003 Jul; 21(4):676-84. PubMed ID: 12798068
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Wnts Modulate Endochondral Ossification During Fracture Healing.
Chua K; Lee VK; Chan C; Yew A; Yeo E; Virshup DM
Front Endocrinol (Lausanne); 2021; 12():667480. PubMed ID: 34108937
[TBL] [Abstract][Full Text] [Related]
18. TRPV1 deletion impaired fracture healing and inhibited osteoclast and osteoblast differentiation.
He LH; Liu M; He Y; Xiao E; Zhao L; Zhang T; Yang HQ; Zhang Y
Sci Rep; 2017 Feb; 7():42385. PubMed ID: 28225019
[TBL] [Abstract][Full Text] [Related]
19. Exogenous PTHrP Repairs the Damaged Fracture Healing of PTHrP+/- Mice and Accelerates Fracture Healing of Wild Mice.
Wang Y; Fang X; Wang C; Ding C; Lin H; Liu A; Wang L; Cao Y
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178186
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
Ulrich-Vinther M; Andreassen TT
Calcif Tissue Int; 2005 Apr; 76(4):280-6. PubMed ID: 15812581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
